Recent News
September 23, 2019
Cancer Causing Agent Found in Zantac Medication
It has recently been reported by the U.S. Food and Drug Administration that a popular heartburn medication, Zantac and some generic ranitdine, contain a probable human cancer-causing agent. Ranitdine, including certain dosages of Zantac, has been sold over-the-counter for years. It is also available by prescription.
An investigation launched by the U.S. and European Union found that a likely carcinogen called N-Nitrosodimethylamine (“NDMA”) was present in Zantac and in some generic ranitidine. Zantac has been recalled in Europe and Canada.
It has also been alleged in a Citizens Petition filed with the FDA and in a private lawsuit that ranitdine forms NDMA and can react with itself. The Citizens Petition also claims that ranitdine likely generates NDMA in the human body. The private lawsuit alleges that the producers of ranitidine drugs knew or should have known about ranitdine and NDMA for years.
The FDA suggests that if you are taking a prescription ranitidine drug that you consult your health care provider about treatment options.
The FDA also suggests that people taking over-the-counter ranitidine consider using other over-the-counter medicines approved for their condition, as there are a variety of such drugs available. The FDA is continuing its investigation.
Sales of Zantac or other ranitdine that contained NDMA may have been in violation of State consumer protection and other laws. People who purchased Zantac may be entitled to refunds or damages.
NEW INFORMATION
October 4, 2019- National retailers – such as, Wal-Mart, CVS, Walgreens and RiteAid- have suspended their sales of Zantac. Stores are now beginning to physically remove the Zantac over the counter product from their shelves.
More information can be found here.
CONTACT US
If you or someone you know has been taking Zantac or generic ranitidine, please contact us at 215-238-1700.
Kohn, Swift & Graf, P.C. is a national leader in consumer litigation. With experienced attorneys and competent support staff, our firm strives to provide the highest quality of service to our clients. We treat each case with careful attention and handle cases nationwide.
Related News
See All NewsKohn Swift Hosts Forum of International Human Rights Lawyers and Advocates
Robert Swift, senior member of Kohn Swift & Graf, hosted a forum on human rights with participants from fifteen countries including human rights lawyers, investigators, and NGO professionals in Philadelphia…
Read more
Three Kohn, Swift and Graf Attorneys Receive BEST LAWYERS© Recognition
The 2024 edition of Best Lawyers© recognizes three Kohn Swift & Graf attorneys: Joseph C. Kohn (antitrust) William E. Hoese (antitrust) Zahra R. Dean (Best Lawyers: Ones to Watch, Mass…
Read more
Kohn Swift and Joseph Kohn are Ranked in Chambers USA’s 2024 Guide in Antitrust Law
Kohn Swift is proud to announce that Kohn Swift and Joseph Kohn have again been ranked among the finest antitrust law firms and attorneys in the country in Chambers USA’s…
Read more